Evidence map›Paper›PMID 2462353›Full record

ReviewThe American journal of pathology1988

Warner-Lambert/Parke-Davis award lecture. Cytokine-mediated activation of vascular endothelium. Physiology and pathology.

J S Pober

Abstract readReview
In one paragraph

Review in The American journal of pathology, 1988. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 152 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
152citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

152 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Relationship between hepatitis C virus (HCV) and insulin resistance, endothelial perturbation, and platelet activation in HIV-HCV-coinfected patients under highly active antiretroviral treatment.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2006
    Trial
  4. Review
  5. The cross-talk between NRF2 and apoptosis in cancer.Medical molecular morphology · 2025
    Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Review
  14. Review
  15. Article
  16. Review
  17. Bias in Medicine: Lessons Learned and Mitigation Strategies.JACC. Basic to translational science · 2021
    Review
  18. Review
  19. Review
  20. Review

92 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

J S PoberDepartment of Pathology, Brigham and Women's Hospital, Boston, Massachusetts 02115.

Funding

PROTEINS OF THE ENDOTHELIAL CELL SURFACER01HL036003 · NHLBI · YALE UNIVERSITY · PI KLUGER, MARTIN S, POBER, JORDAN S · 1985 to 2015
$5.7M
PROTEINS OF THE ENDOTHELIAL CELL SURFACER37HL036003 · NHLBI · YALE UNIVERSITY · PI POBER, JORDAN S · 1992 to 2001
$664k
CORONARY-PRONE BEHAVIOR AND CARDIOVASCULAR REACTIVITYR01HL036027 · NHLBI · UNIVERSITY OF MARYLAND BALT CO CAMPUS · PI DEMBROSKI, THEODORE · 1985 to 1990
–
NHLBI NIH HHS HL-36003NHLBI NIH HHS HL-36027
6 · The paper itself

Abstract

The concept of endothelial cell activation has been extremely useful in understanding endothelial cell function. The morphologic definition of activation from the 1960s has been replaced by a cell biologic definition in the 1980s, but recent studies have suggested that these phenomena are two aspects of the same processes. Moreover, the initial distinction of endothelial cell activation, a beneficial reaction, from injury and dysfunction, a harmful sequence, has become more complex as clinical studies have revealed that activation can produce dysfunction, with or without injury. Most importantly, as our in vivo studies indicate, the concept of activation is a testable hypothesis, as modern immunochemical and molecular biologic techniques have been employed to bridge the gap between in vitro culture experiments and patient-based clinical research.

Indexed as

AnimalsEndothelium, VascularHumansImmunity, CellularInflammationInterferonsInterleukinsLymphotoxin-alphaTumor Necrosis Factor-alphaInterferonsInterleukinsLymphotoxin-alphaTumor Necrosis Factor-alpha

Identifiers

PMID2462353
PMCPMC1880803

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.